CKD-506 Drug-Drug Interaction Study in Healthy Male Subjects

NCT05238948 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

17

Enrollment

INDUSTRY

Sponsor class

Conditions

Drug Drug Interaction

Interventions

DRUG: Midazolam
DRUG: CKD-506

Sponsor

Chong Kun Dang Pharmaceutical